The Impact of Outsourcing Partnerships on Clinical Trial Optimization
The Avoca Group 2014 industry survey is focused on The State of Clinical Outsourcing: The Impact of Outsourcing Partnerships on Clinical Trial Optimization.
The survey responses are confidential, and the individual survey participants' names are not associated with results. The outcome of the survey willbe presented at the 2014 Partnerships in Clinical Trials conference in April.
If you have trouble accessing or completing the survey, please email us at [email protected]
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.